135 related articles for article (PubMed ID: 15929175)
1. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer.
Salminen E; Palmu S; Vahlberg T; Roberts PJ; Söderström KO
World J Gastroenterol; 2005 Jun; 11(21):3245-9. PubMed ID: 15929175
[TBL] [Abstract][Full Text] [Related]
2. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer.
Huh JW; Kim YJ; Kim HR
Ann Surg; 2012 Jan; 255(1):70-8. PubMed ID: 22133895
[TBL] [Abstract][Full Text] [Related]
3. Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma.
Ben-Izhak O; Bar-Chana M; Sussman L; Dobiner V; Sandbank J; Cagnano M; Cohen H; Sabo E
Histopathology; 2002 Dec; 41(6):519-25. PubMed ID: 12460204
[TBL] [Abstract][Full Text] [Related]
4. COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.
Richardsen E; Uglehus RD; Due J; Busch C; Busund LT
Cancer Epidemiol; 2010 Jun; 34(3):316-22. PubMed ID: 20409773
[TBL] [Abstract][Full Text] [Related]
5. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Arch Esp Urol; 1998 Mar; 51(2):204-10. PubMed ID: 9586325
[TBL] [Abstract][Full Text] [Related]
6. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas.
Protzel C; Knoedel J; Zimmermann U; Woenckhaus C; Poetsch M; Giebel J
Histol Histopathol; 2007 Nov; 22(11):1197-204. PubMed ID: 17647192
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma].
Jiang SM; Wang RB; Yu JM; Zhu KL; Mu DB; Xu ZF
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):602-5. PubMed ID: 19102938
[TBL] [Abstract][Full Text] [Related]
8. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
9. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
[TBL] [Abstract][Full Text] [Related]
10. [Survival of patients with laryngeal cancer and some prognostic factors].
Gryczyński M; Kobos J; Murlewska A; Pietruszewska W
Otolaryngol Pol; 2003; 57(3):329-40. PubMed ID: 14524174
[TBL] [Abstract][Full Text] [Related]
11. [Determination of proliferative activity using Ki67 and expression of p53 in colorectal cancer].
Forones NM; Oshima C; Nanogaki S; Tanaka M; Barbosa V
Arq Gastroenterol; 1999; 36(3):122-6. PubMed ID: 10751898
[TBL] [Abstract][Full Text] [Related]
12. Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg; 2009 Jun; 249(6):960-4. PubMed ID: 19474698
[TBL] [Abstract][Full Text] [Related]
13. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
[TBL] [Abstract][Full Text] [Related]
14. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
15. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages.
Abdel-Aziz A; Ahmed RA; Ibrahiem AT
Ann Diagn Pathol; 2017 Oct; 30():1-7. PubMed ID: 28965621
[TBL] [Abstract][Full Text] [Related]
16. Influence of prophylactic apical node dissection of the inferior mesenteric artery on prognosis of colorectal cancer.
Ikeda Y; Shimabukuro R; Saitsu H; Saku M; Maehara Y
Hepatogastroenterology; 2007; 54(79):1985-7. PubMed ID: 18251144
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen Activation System in Rectal Adenocarcinoma.
Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer.
Kim JC; Lee KH; Yu CS; Kim HC; Kim JR; Chang HM; Kim JH; Kim JS; Kim TW
Eur J Surg Oncol; 2004 Apr; 30(3):271-9. PubMed ID: 15028308
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]